Results

Total Results: 900 records

Showing results for "author year description".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/health-careassociated-infections_research-protocol.pdf
    August 26, 2011 - Before and after the intervention, with followup to gauge the durability of the effect (minimum of 1 year … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description … following elements should be included in reporting on the implementation of PSPs: An explicit description … chosen intervention components, and/or an explicit logic model for ―why this PSP should work.‖ A description … Handwashing systematic reviews (limited to English only) Handwashing[mh] AND systematic[sb] #S3 Author
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-health-mobile-apps-disposition-of-comments.pdf
    May 20, 2022 - mental-health-apps/report Published Online: May 20, 2022 2 Summary of Peer Reviewer Comments and Author … effectivehealthcare.ahrq.gov/products/mental-health-apps/report Published Online: May 20, 2022 5 Public Comments and Author … available, we want to inform you of a highly relevant industry standard that was published earlier this year … years of development, ISO published this framework to assess health and wellness apps earlier this year … We have added text to description of objective to clarify this point.
  3. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/ischemic-stroke-treatment_executive.pdf
    January 01, 2011 - They provide an early objective description of the state of science, a potential framework for assessing … We obtained the following information from each report: author identification, year of publication, study
  4. effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-antenatal-care.pdf
    April 01, 2021 - T=JS&PAGE=reference&D=cctr&NEWS=N&AN=CN- 01654073 Author Jennifer Hilgart Conflict of Interest … The findings and conclusions in this document are those of the author(s) who are responsible for its … See Appendix B for detailed description of the criteria. … Related Resources References Author Impact of a New Evidence Review
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-staging_disposition-comments.pdf
    November 20, 2014 - Table 17 provides a general description of the studies—study design, number of enrolled patients.
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/primary-research-design_research.pdf
    January 01, 2012 - The findings and conclusions in this document are those of the author(s), who are responsible for its … For most SRs this information can be identified in the results sections where there is a narrative description … Control or comparators: Compare similarity of placebo planned and description of standard care. 4. … NA Select valid pain score outcome measure, consider adding recurrence or re attendance as 2 year
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/tinnitus_disposition-comments.pdf
    August 23, 2013 - hyberbaric oxygen and also dietary modifications to a separate category within medical interventions description … Additional description has been added as suggested. … least one of them (the 2007 Davis article on Neuromonics) has a potential conflict of interest (the author … I believe the author has created a product (which is a sound based tool and therefore, is probably placed … PMID:17496674 The lead author on this paper is the inventor of Neuromonics and continues to work
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-mobile-devices_research-protocol.pdf
    July 12, 2017 - Types of translational products that fit this description include interactive decision aids; narrative … addressed by systematic reviews if possible. 2008 was chosen as the start date as this was the first year … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-224-depression-children-comments.pdf
    April 10, 2020 - Disposition of Comments: CER 224, Treatment of Depression in Children and Adolescents: A Systematic Review Comparative Effectiveness Review Disposition of Comments Report Research Review Title: Treatment of Depression in Children and Adolescents: A Systematic Review Draft review available for publ…
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-195-uterine-fibroids-final.pdf
    December 01, 2017 - $5 billion, perhaps as much as $17 billion, with roughly $4,624 in costs per woman in the first year … These are rare but ominous: an average of 1,600 new cases occur in the United States each year. … They have poor outcomes with an average 5-year survival of 36 percent if cancer is not isolated to … We categorized interventions using the publication authors’ description. … One small study reported improved bleeding patterns one year after surgery in 12 of 15 women.
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/liver-cancer-therapy_executive.pdf
    May 01, 2013 - is the fifth most common cancer and the third leading cause of cancer death worldwide.1 Overall 5-year … In the other RCT, 3-year cancer- free survival was 43%, 21%, and 23% in the RFA, PEI, and PAI groups … and 42.5% at 2 years for TACE, and 69.8% at 1 year and 58.8% at 2 years for TEA; p = 0.0588). … The clinical heterogeneity was most evident in the description of patient and tumor characteristics … Full description of the patient population is important, as those with, for example, higher ECOG score
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-children_research-protocol.pdf
    June 04, 2010 - The following data will be extracted from each study: author identification, year of publication, source … Adverse events will be recorded for each intervention group including the description of the adverse … Psychotropic practice patterns for youth: a 10-year perspective. … Second generation antipsychotics: FDA status Drug FDA status (year approved) Indications Age group … Second generation antipsychotics: FDA status (continued) Drug FDA status (year approved) Indications
  13. effectivehealthcare.ahrq.gov/sites/default/files/knowledge-brief-2-methods-public-deliberation-130213.pdf
    February 01, 2013 - Both ® 130–450 1 1–2 days Yes Yes Yes Randomly selected Citizens’ Panel In Person 12 A few per year
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/knowledge-brief-2-methods-public-deliberation-130213.pdf
    February 01, 2013 - Both ® 130–450 1 1–2 days Yes Yes Yes Randomly selected Citizens’ Panel In Person 12 A few per year
  15. 13-MDM347013 30..38 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/outcomes-testing-evaluation_research.pdf
    January 01, 2009 - No differences in health indicators were found at 1 year among patients who self-monitored compared … Conclusion Our description of the additional outcomes of testing is necessarily incomplete. … Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing. … Impact of colorectal cancer screening on future lifestyle choices: a three-year randomized controlled
  16. 13-MDM347013 30..38 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/whitepaper4-bossuyt02262010-2.pdf
    January 01, 2009 - No differences in health indicators were found at 1 year among patients who self-monitored compared … Conclusion Our description of the additional outcomes of testing is necessarily incomplete. … Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing. … Impact of colorectal cancer screening on future lifestyle choices: a three-year randomized controlled
  17. effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/registry-of-patient-registries_research.pdf
    April 15, 2019 - developing the condition-specific outcome measure frameworks and classification system in the second year … While each “measurement” may address the same population, the former description provides a static evaluation … ; the latter description addresses an individual patient’s outcome over time. … Data Exchange Standards and Record Description, Volume I, Version 15 (September 2014 - Revised 10-23
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/long-term-care-adults-future_research.pdf
    July 01, 2013 - The findings and conclusions in this document are those of the author(s), who are responsible for its … The nature of HCBS and AL services can vary widely, so a description of services is necessary to judge … The nature of HCBS and AL services can vary widely, so a description of services is necessary to judge … use of LTC services, especially nursing home readmissions, hospitalizations Timing At least one yearDescription of the forthcoming AHRQ report (see LTC Review Draft Executive Summary attachment) b.
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/vaccine-safety_research-protocol.pdf
    September 18, 2012 - costs of influenza infection alone in adults are have been estimated to be as high as $87 billion per year
  20. effectivehealthcare.ahrq.gov/sites/default/files/diabetes-update-2015_disposition-comments.pdf
    January 01, 2015 - We have added a sentence on this in the Executive Summary study characteristics description for the … exact range of study duration if the studies are longer than 1 year. … Results Page 112 The word cerebrovascular is used when the author probably intended to say cardiovascular … Please reconcile.pp. 126 130 139 209 Tables 36 40 41 45 70Please consider adding Author Year and Followup … Most studies had adults with diabetes in the 5-7 year range.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: